269 related articles for article (PubMed ID: 10533618)
1. Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism.
Kalliovalkama J; Jolma P; Tolvanen JP; Kähönen M; Hutri-Kähönen N; Wu X; Holm P; Pörsti I
Cardiovasc Res; 1999 Jun; 42(3):773-82. PubMed ID: 10533618
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of supplementation with whey mineral and potassium on arterial tone in experimental hypertension.
Wu X; Tolvanen JP; Hutri-Kähönen N; Kähönen M; Mäkynen H; Korpela R; Ruskoaho H; Karjala K; Pörsti I
Cardiovasc Res; 1998 Nov; 40(2):364-74. PubMed ID: 9893730
[TBL] [Abstract][Full Text] [Related]
3. High-calcium diet enhances vasorelaxation in nitric oxide-deficient hypertension.
Jolma P; Kalliovalkama J; Tolvanen JP; Kööbi P; Kähönen M; Hutri-Kähönen N; Wu X; Pörsti I
Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H1036-43. PubMed ID: 10993766
[TBL] [Abstract][Full Text] [Related]
4. Ramipril therapy improves arterial dilation in experimental hypertension.
Hutri-Kähönen N; Kähönen M; Tolvanen JP; Wu X; Sallinen K; Pörsti I
Cardiovasc Res; 1997 Jan; 33(1):188-95. PubMed ID: 9059543
[TBL] [Abstract][Full Text] [Related]
5. Arterial function in mineralocorticoid-NaCl hypertension: influence of angiotensin-converting enzyme inhibition.
Mäkynen H; Kähönen M; Wu X; Hutri-Kähönen N; Tolvanen JP; Pörsti I
Pharmacol Toxicol; 1997 Oct; 81(4):180-9. PubMed ID: 9353849
[TBL] [Abstract][Full Text] [Related]
6. Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats.
Kähönen M; Tolvanen JP; Kalliovalkama J; Wu X; Karjala K; Mäkynen H; Pörsti I
Eur J Pharmacol; 1999 Mar; 368(2-3):213-22. PubMed ID: 10193657
[TBL] [Abstract][Full Text] [Related]
7. Exercise enhances vasorelaxation in experimental obesity associated hypertension.
Arvola P; Wu X; Kähönen M; Mäkynen H; Riutta A; Mucha I; Solakivi T; Kainulainen H; Pörsti I
Cardiovasc Res; 1999 Sep; 43(4):992-1002. PubMed ID: 10615427
[TBL] [Abstract][Full Text] [Related]
8. Control of mesenteric arterial tone in vitro in humans and rats.
Hutri-Kähönen N; Kähönen M; Jolma P; Wu X; Sand J; Nordback I; Ylitalo P; Arvola P; Pörsti I
Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):322-30. PubMed ID: 10344531
[TBL] [Abstract][Full Text] [Related]
9. Whey mineral supplementation and arterial tone in mineralocorticoid-NaCl hypertension.
Wu X; Mäkynen H; Korpela R; Pörsti I
Cardiovasc Res; 1996 Dec; 32(6):1115-22. PubMed ID: 9015414
[TBL] [Abstract][Full Text] [Related]
10. Influence of chronic ethanol consumption on arterial tone in young and aged rats.
Kähönen M; Karjala K; Hutri-Kähönen N; Wu X; Jaatinen P; Riihioja P; Hervonen A; Pörsti I
Am J Physiol; 1999 Feb; 276(2):H464-71. PubMed ID: 9950846
[TBL] [Abstract][Full Text] [Related]
11. Effect of celiprolol therapy on arterial dilatation in experimental hypertension.
Tolvanen JP; Wu X; Kähönen M; Sallinen K; Mäkynen H; Pekki A; Pörsti I
Br J Pharmacol; 1996 Nov; 119(6):1137-44. PubMed ID: 8937716
[TBL] [Abstract][Full Text] [Related]
12. Influence of gender on control of arterial tone in experimental hypertension.
Kähönen M; Tolvanen JP; Sallinen K; Wu X; Pörsti I
Am J Physiol; 1998 Jul; 275(1):H15-22. PubMed ID: 9688891
[TBL] [Abstract][Full Text] [Related]
13. Role of NO and angiotensin II in the early development of endothelial functions impairment and cardiac hypertrophy in deoxycorticosterone acetate-salt hypertension.
K-Laflamme A; Oster L; Cardinal R; de Champlain J
Can J Physiol Pharmacol; 1998 Jun; 76(6):665-75. PubMed ID: 9923405
[TBL] [Abstract][Full Text] [Related]
14. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
[TBL] [Abstract][Full Text] [Related]
15. N(G)-nitro-L-arginine methyl ester-induced hypertension and natriuretic peptide gene expression: inhibition by angiotensin II type 1 receptor antagonism.
Suo M; Kalliovalkama J; Pörsti I; Jolma P; Tolvanen JP; Vuolteenaho O; Ruskoaho H
J Cardiovasc Pharmacol; 2002 Sep; 40(3):478-86. PubMed ID: 12198334
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
Bryant CE; Allcock GH; Warner TD
Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
[TBL] [Abstract][Full Text] [Related]
17. Control of vascular tone in isolated mesenteric arterial segments from hypertensive patients.
Hutri-Kähönen N; Kähönen M; Wu X; Sand J; Nordback I; Taurio J; Pörsti I
Br J Pharmacol; 1999 Aug; 127(7):1735-43. PubMed ID: 10455333
[TBL] [Abstract][Full Text] [Related]
18. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
19. Interdependence of contractile responses of rat small mesenteric arteries on nitric oxide and cyclo-oxygenase and lipoxygenase products of arachidonic acid.
Wu XC; Johns E; Michael J; Richards NT
Br J Pharmacol; 1994 Jun; 112(2):360-8. PubMed ID: 7521254
[TBL] [Abstract][Full Text] [Related]
20. Endothelial function in spontaneously hypertensive rats: influence of quinapril treatment.
Kähönen M; Mäkynen H; Wu X; Arvola P; Pörsti I
Br J Pharmacol; 1995 Jul; 115(5):859-67. PubMed ID: 8548188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
